RubrYc Therapeutics, Inc. (“RubrYc”) and iBio, Inc. (“iBio”, NYSEA: IBIO) announced today the closing of ...
RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies, today ...